You Position: Home > Paper

Combination therapy will be the future for the antiviral treatment of chronic hepatitis B

( views:0, downloads:0 )
Author:
No author available
Journal Title:
Chinese Journal of Clinical Infectious Diseases
Issue:
3
DOI:
10.3760/cma.j.issn.1674-2397.2012.03.001
Key Word:
肝炎,乙型,慢性;抗病毒药;联合治疗;Chronic hepatitis B;Antiviral agents;Combination therapy

Abstract´╝Ü 我国《慢性乙型肝炎防治指南(2010年版)》(简称《指南》)指出,慢性乙型肝炎(CHB)治疗的总体目标是"最大限度地长期抑制HBV,减轻肝细胞炎症坏死及肝纤维化,延缓和减少肝脏失代偿、肝硬化、肝细胞癌及其并发症的发生,从而改善患者生活质量和延长存活的时间"[1].由此可见,对于CHB患者,抗病毒治疗是关键措施,这已成为国内外各大CHB防治指南的共识.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn